<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01148043</url>
  </required_header>
  <id_info>
    <org_study_id>NL32030.101.10</org_study_id>
    <nct_id>NCT01148043</nct_id>
  </id_info>
  <brief_title>Pharmacological Treatment In Osteoarthritis</brief_title>
  <acronym>FABIO</acronym>
  <official_title>Pharmacological Treatment In Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maasstad Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maasstad Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy of hydroxychloroquine in hand
      osteoarthritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Osteoarthritis is the most common joint disease, most frequently involving the hands,
      resulting in pain, stiffness and loss of hand function. At present, there is no option to
      prevent the onset or the progression of hand osteoarthritis (OA). It is believed that
      inflammation plays an important role in the pathogenesis of OA and that anti-inflammatory
      drugs might be an effective treatment for OA. Anti-malarial agents like chloroquine and
      hydroxychloroquine are potential anti-inflammatory drugs and hydroxychloroquine has already
      proven to be an effective suppressor of inflammation in rheumatoid arthritis. Several
      previous studies with hydroxychloroquine in hand OA also showed a possible effect on pain and
      inflammation, but these studies were mostly retrospective with a small number of patients.
      This is the first prospective, randomised, placebo-controlled study to determine the effect
      of hydroxychloroquine in hand osteoarthritis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity measured by 100 mm Visual Analog Scale (VAS)</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hand function measured by Arthritis Impact Measurement Scales 2 short form (AIMS2-SF) and Australian/Canadian Osteoarthritis Hand Index (AUSCAN)</measure>
    <time_frame>6, 12 and 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity measured by 100 mm VAS</measure>
    <time_frame>6, 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological progression measured by the anatomical lesion progression system from Verbruggen et al.</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine</intervention_name>
    <description>200 mg capsule, 2 capsules QD for 24 weeks.</description>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
    <other_name>Plaquenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cellulose</intervention_name>
    <description>capsule, 2 capsules QD for 24 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 40 years

          -  Primary hand OA according to the ACR classification

          -  Heberden or Bouchard nodule or Kellgren-Lawrence grade 1, 2 or 3 changes in ≥ 2
             symptomatic joints

          -  Pain in the dominant hand ≥ 12 months

          -  Use of an NSAID for ≥ 1 episode of pain

          -  Written informed consent

        Exclusion Criteria:

          -  Secondary hand OA, e.g. haemochromatoses, rheumatoid arthritis, posttraumatic

          -  Kellgren-Lawrence grade 4 OA

          -  Use of hydroxychloroquine within 3 months before entering the study

          -  Use of NSAIDs or corticosteroids within 7 days before entering the study

          -  Retinopathy

          -  Myasthenia gravis

          -  Known allergy or hypersensitivity for hydroxychloroquine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natalja M Basoski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maasstad Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Admiraal de Ruyter Hospital</name>
      <address>
        <city>Goes</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maasstad Hospital</name>
      <address>
        <city>Rotterdam</city>
        <zip>3079DZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sint Franciscus Gasthuis</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vlietland Hospital</name>
      <address>
        <city>Schiedam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ZorgSaam Zeeuws-Vlaanderen</name>
      <address>
        <city>Terneuzen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2010</study_first_submitted>
  <study_first_submitted_qc>June 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2010</study_first_posted>
  <last_update_submitted>April 10, 2015</last_update_submitted>
  <last_update_submitted_qc>April 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maasstad Hospital</investigator_affiliation>
    <investigator_full_name>WeiChing Lee</investigator_full_name>
    <investigator_title>pharmacist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxychloroquine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

